home / stock / incr / incr news


INCR News and Press, Intercure Ltd. From 06/15/22

Stock Information

Company Name: Intercure Ltd.
Stock Symbol: INCR
Market: NASDAQ
Website: intercure.co

Menu

INCR INCR Quote INCR Short INCR News INCR Articles INCR Message Board
Get INCR Alerts

News, Short Squeeze, Breakout and More Instantly...

INCR - Buying Into A Down Market

Ted Waller returns to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing. Buying special situations and what stocks are more concerning. For further detai...

INCR - InterCure Is Growing In The Massive Global Cannabis Market

Most of cannabis industry growth will occur outside North America. The road to global growth starts with medical cannabis. InterCure is leveraging its expertise to take advantage of domestic and international growth. For further details see: InterCure Is Growing In The M...

INCR - InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel

NEW YORK and TORONTO and HERZLIYA, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) announced today the grand opening of its flagship Cookies pharmacy in Be'er Sheva, the largest city in ...

INCR - Still A Lot More Work To Do In The Cannabis Industry (Podcast Transcript)

Michael Auerbach, Chairman of The Parent Company, updates us on the growth that hasn't shown up the way we expected. InterCure and the Israeli market. His new ETF PUNK which came on the scene and shorted Meta. For further details see: Still A Lot More Work To Do In The C...

INCR - InterCure Ltd.'s (INCR) CEO Alex Rabinovitch on Q1 2022 Results - Earnings Call Transcript

InterCure Ltd. (INCR) Q1 2022 Earnings Conference Call May 17, 2022 8:00 A.M. ET Company Participants Adam Haliva - Communications Officer Alex Rabinovitch - Chief Executive Officer Amos Cohen - Chief Financial Officer Conference Call Participants Matt Bottomley - Canaccord Presentation Opera...

INCR - InterCure reports Q1 results

InterCure press release (NASDAQ:INCR): Q1 Revenue of C$34.41M (+163.9% Y/Y). Adjusted EBITDA increased almost 110% year-over-year to C$8 million. For further details see: InterCure reports Q1 results

INCR - InterCure Begins 2022 with Record Breaking First Quarter Financial Results

Record revenue of $3 4 1 million in the first quarter of 2022 Adjusted EBITDA 2 increased almost 1 1 0% year-over-year to $8 million Net income of $ 6 million for the Q1 of 2022 compare d to ...

INCR - INCR, IREN and TNON among pre market losers

Chimerix (CMRX) -51% on Q1 results. Iris Energy (IREN) -28%. Weber (WEBR) -12% on Q2 results. Wix.com (WIX) -9% on Q1 results. Blue Water Vaccines (BWV) -8%. on Q1 results. InterCure (INCR) -5%. Tenon Medical (TNON) -5%. For further details see: INCR, ...

INCR - InterCure to Release its Q1 2022 Results and Hold a Conference Call

NEW YORK and TORONTO and HERZLIYA, Israel, May 16, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the first quarter of 2022 after ...

INCR - InterCure to Participate in Upcoming Investor Conferences in May 2022

NEW YORK, TORONTO, and HERZLIYA, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that that Alex Rabinovitch, Chief Executive Officer and Amos Cohen, Chief Financi...

Previous 10 Next 10